RAPAFLO (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the RAPAFLO drug offered from Actavis Pharma, Inc.. This Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | silodosin |
| SUBSTANCE NAME: | SILODOSIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-03-23 |
| END MARKETING DATE: | 0000-00-00 |
RAPAFLO HUMAN PRESCRIPTION DRUG Details:
| Item Description | RAPAFLO from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 4(mg/1) |
| START MARKETING DATE: | 2009-03-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 52544-151_43977e12-80e8-45bc-b59b-19f851047ebb |
| PRODUCT NDC: | 52544-151 |
| APPLICATION NUMBER: | NDA022206 |
Other SILODOSIN Pharmaceutical Manufacturers / Labelers:
